| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f8b21abc3e99d7971c9019578cd9e5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f964219209ae29591b86d6b0df5c9520 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34 |
| filingDate |
1983-10-07^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6d345cdf37a66c354a32874e337f4c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b207509db365b4307d85a1d599e4ad1 |
| publicationDate |
1985-11-13^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CS-238038-B1 |
| titleOfInvention |
Medical drug with antivirus effect |
| abstract |
Certain esters of 3-(adenin-9-yl)-2-hydroxypropanoic acid are disclosed which exhibit an improved broad spectrum antiviral activity while having a low toxicity for living cells. They can be used for treatment of virus diseases in human and veterinary practice. |
| priorityDate |
1983-10-07^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |